Literature DB >> 24657786

The impact of CSFV on the immune response to control infection.

Joan Tarradas1, Maria Eugenia de la Torre1, Rosa Rosell2, Lester Josue Perez3, Joan Pujols4, Marta Muñoz1, Iván Muñoz1, Sara Muñoz1, Xavier Abad1, Mariano Domingo5, Lorenzo Fraile6, Llilianne Ganges7.   

Abstract

The severity of the acute form of CSF is responsible for the high mortality rate and has been the subject of many studies. Nevertheless, some animals are likely to develop a mild, chronic, or unapparent form of the disease. Paradoxically, this clinical form of the disease has not been well studied, especially regarding its pathogenesis. In this study, we investigated the infection in domestic pigs that is caused by the CSFV Cat01 strain, which is responsible for the 2001-2002 CSFV outbreak in Catalonia, Spain, and which caused mild and nonspecific clinical signs compared to the infection that is caused by another CSFV strain that is responsible for inducing severe clinical symptoms of disease. We assessed the impact of the CSFV infection in the immune system of domestic pigs, mainly on the kinetics of different cytokines, such as IFN-α (innate immunity) and IFN-γ (adaptive immune response), during the first weeks after infection. In addition, we evaluated the impact on the induction of the humoral response and its relation to the course of infection and the RNA CSFV viral load. The IFN-α levels in the serum samples from the pigs that developed a milder form of the CSF disease (infected with Cat01 strain) were lower than those that were detected in the pig with severe clinical CSF signs (Margarita strain). After infection with Cat01 strain, the IFN-γ levels in response to CSFV were detected in addition to the humoral response. Interestingly, in the serum samples of these animals, we detected the lowest load of CSFV RNA. Similarly, the lowest viral load levels were detected in the tonsils of these pigs. Both the T cells and the humoral response that were generated in most of the pigs that were infected with strain Cat01 may be related to the protection in the symptom progression of CSF against this viral strain. These results explain the antiviral role of IFN-γ in the absence of an antibody response. Likewise, these results corroborate the relevance and relationship that exists between the intensity of the T cell response and the protection against CSFV replication. Additionally, these results also explain how the failure to induce optimal levels of humoral and cellular responses after CSFV infection promotes the spread and persistence of the virus.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CSFV; Course of infection; Immune response; Virus detection

Mesh:

Substances:

Year:  2014        PMID: 24657786     DOI: 10.1016/j.virusres.2014.03.004

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  17 in total

1.  Multiplex detection of six swine viruses on an integrated centrifugal disk using loop-mediated isothermal amplification.

Authors:  Xiangfen Yuan; Jizhou Lv; Xiangmei Lin; Chunyan Zhang; Junhua Deng; Caixia Wang; Xiaopan Fan; Yonggui Wang; Hui Xu; Shaoqiang Wu
Journal:  J Vet Diagn Invest       Date:  2019-04-04       Impact factor: 1.279

2.  Postnatal persistent infection with classical Swine Fever virus and its immunological implications.

Authors:  Sara Muñoz-González; Nicolas Ruggli; Rosa Rosell; Lester Josué Pérez; Maria Teresa Frías-Leuporeau; Lorenzo Fraile; Maria Montoya; Lorena Cordoba; Mariano Domingo; Felix Ehrensperger; Artur Summerfield; Llilianne Ganges
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

3.  Classical Swine Fever Virus vs. Classical Swine Fever Virus: The Superinfection Exclusion Phenomenon in Experimentally Infected Wild Boar.

Authors:  Sara Muñoz-González; Marta Pérez-Simó; Andreu Colom-Cadena; Oscar Cabezón; José Alejandro Bohórquez; Rosa Rosell; Lester Josué Pérez; Ignasi Marco; Santiago Lavín; Mariano Domingo; Llilianne Ganges
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

4.  Early protection events in swine immunized with an experimental live attenuated classical swine fever marker vaccine, FlagT4G.

Authors:  Lauren G Holinka; Vivian O'Donnell; Guillermo R Risatti; Paul Azzinaro; Jonathan Arzt; Carolina Stenfeldt; Lauro Velazquez-Salinas; Jolene Carlson; Douglas P Gladue; Manuel V Borca
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

5.  Efficacy of a live attenuated vaccine in classical swine fever virus postnatally persistently infected pigs.

Authors:  Sara Muñoz-González; Marta Perez-Simó; Marta Muñoz; José Alejandro Bohorquez; Rosa Rosell; Artur Summerfield; Mariano Domingo; Nicolas Ruggli; Llilianne Ganges
Journal:  Vet Res       Date:  2015-07-09       Impact factor: 3.683

Review 6.  Immune Responses Against Classical Swine Fever Virus: Between Ignorance and Lunacy.

Authors:  Artur Summerfield; Nicolas Ruggli
Journal:  Front Vet Sci       Date:  2015-05-07

7.  African swine fever virus infection in Classical swine fever subclinically infected wild boars.

Authors:  Oscar Cabezón; Sara Muñoz-González; Andreu Colom-Cadena; Marta Pérez-Simó; Rosa Rosell; Santiago Lavín; Ignasi Marco; Lorenzo Fraile; Paloma Martínez de la Riva; Fernando Rodríguez; Javier Domínguez; Llilianne Ganges
Journal:  BMC Vet Res       Date:  2017-08-01       Impact factor: 2.741

Review 8.  Classical Swine Fever-An Updated Review.

Authors:  Sandra Blome; Christoph Staubach; Julia Henke; Jolene Carlson; Martin Beer
Journal:  Viruses       Date:  2017-04-21       Impact factor: 5.048

9.  Low CD4/CD8 ratio in classical swine fever postnatal persistent infection generated at 3 weeks after birth.

Authors:  José Alejandro Bohórquez; Miaomiao Wang; Marta Pérez-Simó; Enric Vidal; Rosa Rosell; Llilianne Ganges
Journal:  Transbound Emerg Dis       Date:  2018-12-09       Impact factor: 5.005

10.  High-Resolution Profiling of Innate Immune Responses by Porcine Dendritic Cell Subsets in vitro and in vivo.

Authors:  Gaël Auray; Stephanie C Talker; Irene Keller; Sylvie Python; Markus Gerber; Matthias Liniger; Llilianne Ganges; Rémy Bruggmann; Nicolas Ruggli; Artur Summerfield
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.